262 related articles for article (PubMed ID: 24937459)
1. Leukemia propagating cells rebuild an evolving niche in response to therapy.
Duan CW; Shi J; Chen J; Wang B; Yu YH; Qin X; Zhou XC; Cai YJ; Li ZQ; Zhang F; Yin MZ; Tao Y; Mi JQ; Li LH; Enver T; Chen GQ; Hong DL
Cancer Cell; 2014 Jun; 25(6):778-93. PubMed ID: 24937459
[TBL] [Abstract][Full Text] [Related]
2. Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
Uy GL; Hsu YM; Schmidt AP; Stock W; Fletcher TR; Trinkaus KM; Westervelt P; DiPersio JF; Link DC
Leuk Res; 2015 Dec; 39(12):1437-42. PubMed ID: 26467815
[TBL] [Abstract][Full Text] [Related]
3. Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL.
Balandrán JC; Dávila-Velderrain J; Sandoval-Cabrera A; Zamora-Herrera G; Terán-Cerqueda V; García-Stivalet LA; Limón-Flores JA; Armenta-Castro E; Rodríguez-Martínez A; Leon-Chavez BA; Vallejo-Ruiz V; Hassane DC; Pérez-Tapia SM; Ortiz-Navarrete V; Guzman ML; Pelayo R
Front Immunol; 2021; 12():746492. PubMed ID: 34737747
[TBL] [Abstract][Full Text] [Related]
4. Targeting the bone marrow microenvironment in acute leukemia.
Karantanou C; Godavarthy PS; Krause DS
Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program.
Carol H; Fan MM; Harasym TO; Boehm I; Mayer LD; Houghton P; Smith MA; Lock RB
Pediatr Blood Cancer; 2015 Jan; 62(1):65-71. PubMed ID: 25203866
[TBL] [Abstract][Full Text] [Related]
6. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.
Boyerinas B; Zafrir M; Yesilkanal AE; Price TT; Hyjek EM; Sipkins DA
Blood; 2013 Jun; 121(24):4821-31. PubMed ID: 23589674
[TBL] [Abstract][Full Text] [Related]
7. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
8. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
[TBL] [Abstract][Full Text] [Related]
9. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Hongo T; Yajima S; Sakurai M; Horikoshi Y; Hanada R
Blood; 1997 Apr; 89(8):2959-65. PubMed ID: 9108416
[TBL] [Abstract][Full Text] [Related]
10. The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.
Gaynes JS; Jonart LM; Zamora EA; Naumann JA; Gossai NP; Gordon PM
Haematologica; 2017 Apr; 102(4):e136-e139. PubMed ID: 28034988
[No Abstract] [Full Text] [Related]
11. The multiface morphology of acute leukemia.
Mittelman M; Floru S; Djaldetti M
Haematologia (Budap); 1993; 25(3):205-13. PubMed ID: 8119633
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia.
Tang C; Li MH; Chen YL; Sun HY; Liu SL; Zheng WW; Zhang MY; Li H; Fu W; Zhang WJ; Liang AB; Tang ZH; Hong DL; Zhou BS; Duan CW
J Exp Clin Cancer Res; 2018 Aug; 37(1):204. PubMed ID: 30157922
[TBL] [Abstract][Full Text] [Related]
13. Romidepsin enhances the efficacy of cytarabine
Cheung LC; Cruickshank MN; Hughes AM; Singh S; Chua GA; Ford J; Ferrari E; Oommen J; Malinge S; Lock RB; Kees UR; Kotecha RS
Haematologica; 2019 Jul; 104(7):e300-e303. PubMed ID: 30679330
[No Abstract] [Full Text] [Related]
14. Dormancy Stems the Tide of Chemotherapy.
Pal D; Heidenreich O; Vormoor J
Cancer Cell; 2016 Dec; 30(6):825-826. PubMed ID: 27960078
[TBL] [Abstract][Full Text] [Related]
15. In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche.
Zong H; Sen S; Zhang G; Mu C; Albayati ZF; Gorenstein DG; Liu X; Ferrari M; Crooks PA; Roboz GJ; Shen H; Guzman ML
Leukemia; 2016 Jul; 30(7):1582-6. PubMed ID: 26669973
[No Abstract] [Full Text] [Related]
16. PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions.
Podszywalow-Bartnicka P; Maifrede S; Le BV; Nieborowska-Skorska M; Piwocka K; Skorski T
Leuk Lymphoma; 2019 Jan; 60(1):262-264. PubMed ID: 29932782
[No Abstract] [Full Text] [Related]
17. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C
Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317
[TBL] [Abstract][Full Text] [Related]
18. Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL.
Kong Y; Wu YL; Song Y; Shi MM; Cao XN; Zhao HY; Qin YZ; Lai YY; Jiang H; Jiang Q; Huang XJ
J Transl Med; 2017 Aug; 15(1):184. PubMed ID: 28854975
[TBL] [Abstract][Full Text] [Related]
19. Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche.
Ma C; Witkowski MT; Harris J; Dolgalev I; Sreeram S; Qian W; Tong J; Chen X; Aifantis I; Chen W
Sci Adv; 2020 Oct; 6(44):. PubMed ID: 33127669
[TBL] [Abstract][Full Text] [Related]
20. Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia.
Wu L; Chatla S; Lin Q; Chowdhury FA; Geldenhuys W; Du W
Nat Commun; 2021 Nov; 12(1):6936. PubMed ID: 34836965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
